Literature DB >> 20107048

Proteasomal degradation of glutamine synthetase regulates schwann cell differentiation.

Fuminori Saitoh1, Toshiyuki Araki.   

Abstract

Rapid saltatory nerve conduction is facilitated by myelin structure, which is composed of Schwann cells in the peripheral nervous system. Schwann cells drastically change their phenotype following peripheral nerve injury. These phenotypic changes are required for efficient degeneration/regeneration. We previously identified ZNRF1 as an E3 ubiquitin ligase containing a RING finger motif, whose expression is upregulated in the Schwann cells following nerve injury. This suggested that posttranscriptional regulation of protein expression in Schwann cells may be involved in their phenotypic changes during nerve degeneration/regeneration. Here we report the identification of glutamine synthetase (GS), an enzyme that synthesizes glutamine using glutamate and ammonia, as a substrate for E3 activity of ZNRF1 in Schwann cells. GS is known to be highly expressed in differentiated Schwann cells, but its functional significance has remained unclear. We found that during nerve degeneration/regeneration, GS expression is controlled mostly by ZNRF1-dependent proteasomal degradation. We also found that Schwann cells increase oxidative stress upon initiation of nerve degeneration, which promotes carbonylation and subsequent degradation of GS. Surprisingly, we discovered that GS expression regulates Schwann cell differentiation; i.e., increased GS expression promotes myelination via its enzymatic activity. Among the substrates and products of GS, increased glutamate concentration inhibited myelination and yet promoted Schwann cell proliferation by activating metabotropic glutamate receptor signaling. This would suggest that GS may exert its effect on Schwann cell differentiation by regulating glutamate concentration. These results indicate that the ZNRF1-GS system may play an important role in correlating Schwann cell metabolism with its differentiation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20107048      PMCID: PMC6633780          DOI: 10.1523/JNEUROSCI.3591-09.2010

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  27 in total

1.  Astrocyte-like glia associated with the embryonic development of the central complex in the grasshopper Schistocerca gregaria.

Authors:  George Boyan; Michael Loser; Leslie Williams; Yu Liu
Journal:  Dev Genes Evol       Date:  2011-05-10       Impact factor: 0.900

2.  ZNRF1 promotes Wallerian degeneration by degrading AKT to induce GSK3B-dependent CRMP2 phosphorylation.

Authors:  Shuji Wakatsuki; Fuminori Saitoh; Toshiyuki Araki
Journal:  Nat Cell Biol       Date:  2011-11-06       Impact factor: 28.824

3.  PAX5 alteration-associated gene-expression signatures in B-cell acute lymphoblastic leukemia.

Authors:  Zhen Shang; Yuechao Zhao; Kuangguo Zhou; Yanling Xu; Wei Huang
Journal:  Int J Hematol       Date:  2013-03-26       Impact factor: 2.490

4.  Glutamine synthetase stability and subcellular distribution in astrocytes are regulated by γ-aminobutyric type B receptors.

Authors:  Deborah Huyghe; Yasuko Nakamura; Miho Terunuma; Mathilde Faideau; Philip Haydon; Menelas N Pangalos; Stephen J Moss
Journal:  J Biol Chem       Date:  2014-08-29       Impact factor: 5.157

Review 5.  An update of biochemical markers of hepatocellular carcinoma.

Authors:  Abdulaziz Ajlan M AlSalloom
Journal:  Int J Health Sci (Qassim)       Date:  2016-01

6.  Glutamine synthetase functions as a negative growth regulator in glioma.

Authors:  Ying Yin; Weifeng Sun; Jie Xiang; Lingxiao Deng; Bin Zhang; Ping Xie; Weizhen Qiao; Jian Zou; Chunxing Liu
Journal:  J Neurooncol       Date:  2013-06-19       Impact factor: 4.130

7.  ZNRF2 is released from membranes by growth factors and, together with ZNRF1, regulates the Na+/K+ATPase.

Authors:  Gerta Hoxhaj; Ayaz Najafov; Rachel Toth; David G Campbell; Alan R Prescott; Carol MacKintosh
Journal:  J Cell Sci       Date:  2012-07-13       Impact factor: 5.285

8.  Glutamine Triggers Acetylation-Dependent Degradation of Glutamine Synthetase via the Thalidomide Receptor Cereblon.

Authors:  T Van Nguyen; J Eugene Lee; Michael J Sweredoski; Seung-Joo Yang; Seung-Je Jeon; Joseph S Harrison; Jung-Hyuk Yim; Sang Ghil Lee; Hiroshi Handa; Brian Kuhlman; Ji-Seon Jeong; Justin M Reitsma; Chul-Seung Park; Sonja Hess; Raymond J Deshaies
Journal:  Mol Cell       Date:  2016-03-17       Impact factor: 17.970

9.  Piezo2 mechanosensitive ion channel is located to sensory neurons and nonneuronal cells in rat peripheral sensory pathway: implications in pain.

Authors:  Seung Min Shin; Francie Moehring; Brandon Itson-Zoske; Fan Fan; Cheryl L Stucky; Quinn H Hogan; Hongwei Yu
Journal:  Pain       Date:  2021-11-01       Impact factor: 6.961

10.  Glutamine supplementation in a child with inherited GS deficiency improves the clinical status and partially corrects the peripheral and central amino acid imbalance.

Authors:  Johannes Häberle; Noora Shahbeck; Khalid Ibrahim; Bernhard Schmitt; Ianina Scheer; Ruth O'Gorman; Farrukh A Chaudhry; Tawfeg Ben-Omran
Journal:  Orphanet J Rare Dis       Date:  2012-07-25       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.